Preclinical characterization of a PD-1-CD28 fusion receptor in CD4+ T cells for T cell-based immunotherapy of pancreatic cancer and Non-Hodgkin Lymphoma

Publication date: March 2018
Source:European Journal of Cancer, Volume 92, Supplement 1
Author(s): F. Rataj, F. Kraus, S. Grassmann, Michael Chaloupka, Justyna Ogonek, Jin Zhang, Svenja Rausch, Stefan Endres, Sebastian Kobold




http://ift.tt/2IwD07o